H.R. 4158 · 116th Congress
CURE High Drug Prices Act
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 116th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
D
PingreeSponsorNo cosponsors.
Combatting Unreasonable Rises and Excessively High Drug Prices Act or the CURE High Drug Prices Act
What it does: CRS summary · Introduced in House · Aug 2, 2019
Combatting Unreasonable Rises and Excessively High Drug Prices Act or the CURE High Drug Prices Act
This bill prohibits price gouging by manufacturers of prescription drugs (including a combination of a drug, device, or biological product) that are covered by a federal health care program. The bill specifies percentage increases in price at which price gouging is presumed.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: CURE High Drug Prices Act
Also known as: Combatting Unreasonable Rises and Excessively High Drug Prices Act
Latest action (Aug 5, 2019): Referred to the Subcommittee on Health.
Policy area: Health · Origin: House · Introduced: Aug 2, 2019
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.